Tandem Diabetes Care (NASDAQ:TNDM) announces the commercial launch of its t:slim X insulin pump with Control-IQ technology, an advanced hybrid-closed loop feature designed to help increase blood sugar time in range (70-180 mg/dL).
The company says the system delivers automatic correction boluses in addition to adjusting insulin to help prevent high and low blood sugar. The system integrates with Dexcom’s (NASDAQ:DXCM) G6 continuous glucose monitoring (CGM) which requires no fingersticks for calibration or diabetes treatment decisions.
TNDM is up 1% after hours.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.